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ABSTRACT
Background: The long-term prognostic implications of stable 
coronary artery disease (CAD) in young patients are currently 
unknown. The objective of this study was to evaluate the 
prognosis of young adult patients diagnosed with stable 
CAD who were treated by percutaneous coronary interven-
tion (PCI) and followed for up to ten years. Methods: The 
study population consisted of young patients (age below the 
10th percentile) from a group of 1,394 consecutive patients 
treated for stable CAD using the percutaneous approach. 
The patients’ characteristics were prospectively collected. 
After the procedure, outpatient follow-up was conducted, 
including the analysis of the electronic medical records 
and telephone contact, whenever required. The primary 
outcome was overall mortality, and the secondary outcome 
was cardiovascular mortality. Results: A total of 140 patients 
were selected, with a mean age of 43.7 ± 4 years (ranging 
from 26 to 48 years), who were predominantly males 
(76.4%). Diabetes mellitus was present in approximately 
one fifth of the patients, and half of them had a previous 
myocardial infarction. Patients were followed for an ave-
rage of 94.6 ± 36.2 months, and the overall mortality after 
ten years was 6%, with a cardiac mortality of 5.3%. All 
patients who died had a successful index procedure, and 
only one of the cases did not have a previous myocardial 
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RESUMO
Prognóstico Tardio em Jovens com Coronariopatia 
Estável: Evolução em 10 Anos após Intervenção 
Coronária Percutânea
Introdução: Atualmente são ainda desconhecidas as implicações 
prognósticas tardias da doença arterial coronária (DAC) estável 
em pacientes jovens. O objetivo deste trabalho foi avaliar o 
prognóstico de pacientes adultos jovens com diagnóstico de DAC 
estável, tratados por meio de intervenção coronária percutânea 
(ICP) e acompanhados por até 10 anos. Métodos: A população 
do estudo foi constituída por pacientes jovens (idade abaixo 
do 10o percentil) de um grupo de 1.394 pacientes consecutivos 
tratados para DAC estável por via percutânea. As características 
dos pacientes foram coletadas prospectivamente. Após o pro-
cedimento foi realizado seguimento ambulatorial, com análise 
do prontuário hospitalar eletrônico e contato telefônico, quando 
necessário. O desfecho primário foi a mortalidade geral e o 
desfecho secundário, a mortalidade cardiovascular. Resultados: 
Foram selecionados 140 pacientes, com média de idade de 
43,7 ± 4 anos (mínimo de 26 anos e máximo de 48 anos), 
predominantemente do sexo masculino (76,4%). Diabetes melito 
estava presente em aproximadamente um quinto dos pacientes e 
metade apresentava infarto prévio. Os pacientes foram seguidos 
por uma média de 94,6 ± 36,2 meses e a mortalidade geral no 
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infarction. Conclusions: In this clinical practice, young 





DESCRIPTORS: Angioplasty. Coronary disease. Age groups. 
Prognosis.
S everal studies defining the role of percutaneous coronary intervention (PCI) in coronary artery disease (CAD) have discussed the individualised 
indication of this procedure, aiming to better identify 
patients who will benefit from interventional treatment. 
However, due to the higher prevalence of CAD after the 
sixth decade of life,1 much of the available scientific 
information about the disease has come from studies 
in which young patients are underrepresented.2,3 Few 
studies have been focused on the implications of CAD 
in young populations,2–6 and even these studies have 
focused on the disease presenting as an acute coronary 
syndrome.3,6
The prognostic implications of CAD in its stable 
form are still currently unknown in young patients. In 
theory, the early onset of the disease could indicate a 
worse long-term prognosis, due to the possible increased 
aggressiveness of the disease that led to its manifestation 
at a young age. Conversely, diagnosis at an early stage 
could represent an opportunity for clinical actions to 
prevent atherosclerotic progression.
The objective of this study was to evaluate the clini-
cal characteristics and late mortality in a population of 




The study population was retrospectively selected 
from a cohort of 1,394 patients living in the State of São 
Paulo who were consecutively admitted between 1998 
and 2003 by the Brazilian Unified Health System (Sistema 
Único de Saúde – SUS) for the percutaneous treatment 
of chronic stable coronary disea se, defined as the pres-
ence of angina or documented silent ischemia with no 
acute events in the previous 30 days. Data collection 
was approved by the ethics committee of the institution.
The age range of the population treated in this 
centre below the 10th percentile for age was defined 
as young, which totalled 140 individuals. The clinical 
seguimento de 10 anos foi de 6%, com mortalidade cardíaca 
de 5,3%. Todos os pacientes que morreram obtiveram sucesso 
no procedimento inicial e apenas um dos casos não apresentava 
infarto prévio. Conclusões: Em nossa prática clínica, pacientes 
jovens com coronariopatia crônica tratados com ICP mostraram 
ter bom prognóstico tardio.
DESCRITORES: Angioplastia. Doença das coronárias. Grupos 
etários. Prognóstico. Stents. Anticoagulantes. Fondaparinux.
and angiographic characteristics of the study popula-
tion were prospectively registered for all patients. The 
intervention technique and strategy were decided by 
the hemodynamics specialist in charge of each case. 
Only bare-metal stents were used.
Clinical follow-up
The follow-up and recording of in-hospital mortality 
were obtained for all patients after the index procedure. 
The follow-up evaluation after hospital discharge was 
performed at the outpatient cardiology clinic of the 
institution and verified through the analysis of hospital 
records or by telephone contact, when necessary. The 
cause of death was classified as cardiac or non-cardiac. 
The primary endpoint of this study was the occurrence 
of death from any cause, and cardiac mortality was 
assessed as a secondary outcome.
Cardiac death was defined as any death except that 
with an unequivocal non-cardiac cause, as demons-
trated by data in the medical file or an autopsy or as 
reported on the death certificate.
Statistical analysis
Categorical variables were shown as percentages, 
and continuous variables were shown as means and 
standard deviations. Comparison between cate gorical 
variables was performed using the chi-squared test. 
The cumulative incidence of death was estimated ac-
cording to the Kaplan-Meier method. Patients lost to 
follow-up were considered at risk until the date of the 
last contact, from which point they were eliminated 
from the analysis.
RESULTS
Patients had a mean age of 43.7 ± 4 years (minimum 
26 years and maximum 48 years) and were predominantly 
male (76.4%). At the time of the index procedure, one 
quarter of the patients were obese (defined as body mass 
index [BMI] >  30  kg/m2), and two thirds (66.4%) had 
dyslipidaemia. One third (31.4%) were active smokers, 
and diabetes was present in approximately one fifth 
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(20.7%). Half of the patients (52.1%) had experienced 
a previous myocardial infarction, and most patients 
(87.9%) were referred due to complaints of exertional 
angina. The clinical and procedural characteristics are 
shown in Table 1.
At admission, one quarter (26.4%) of the pa-
tients received beta-blockers, and the same propor-
tion used angiotensin-converting enzyme inhibitors. 
Approximately one third (35%) used statins. Over half 
of the patients (57.1%) were using aspirin when they 
were referred to treatment, which did not differ between 
patients with and without prior acute myocardial infarc-
tion (58.9% vs. 55.2%; P  =  0.79). Regarding statins, 
their use was also reduced in patients in secondary 
prevention after acute myocardial infarctions and in 
patients in primary prevention (35.6% vs. 34.3%; 
P  =  0.98). Coronary stents were used in the major-
ity of patients (87.9%), and 1.18 ± 0.69 stents were 
implanted per patient; all stents used were bare-metal.
Patients were followed for a mean of 94.6 ± 36.2 
months, and the overall mortality rate found in the 
following ten years was 6% (five cases) (Figure 1), with 
a cardiac mortality of 5.3% (one case of non-cardiac 
death) (Figure 2). There were no cases of death during 
hospitalisation. The only case of non-cardiac death was 
due to suicide at 30 days of follow-up. The observed 
low incidence of primary and secondary outcomes 
did not allow for the the analysis of independent risk 
predictors. All cases of death had successful initial 

















































Figure 2 – Cardiac mortality curve.
Figure 1 – Overall mortality curve.
TABLE 1  
















































* Defined as body mass index (BMI) > 30 kg/m².
† Available for 98 patients (70%).
‡ Defined by angiographic success in all lesions with attempted 
PCI in the absence of myocardial infarction or periprocedural 
death.
AMI = acute myocardial infarction; CHF = congestive 
heart failure; PCI = percutaneous coronary intervention;  
CABG = coronary artery bypass graft; LCA = left main coronary 
artery.
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case of death had no previous myocardial infarction. 
Among the deaths due to cardiac causes, the mean 
follow-up was 78.5  ±  47.5 months. Two cases were 
described as having acute myocardial infarction as the 
primary cause of death, one case of sudden death was 
described during a haemodialysis session, and one 
case was considered to have an unknown aetiology. 
It was not possible to establish a causal connection 
between the index procedures and the later deaths 
in the reported cases.
DISCUSSION
The present study aimed to evaluate the hypothesis 
that the diagnosis of chronic stable coronary disease 
at a young age would be associated with a poor late 
prognosis. In this study, an overall mortality of 6% 
after ten years of evolution was observed. While a 
formal comparison is not possible, this result does 
not express a considerably increased risk of death. 
Although a more consistent analysis is not allowed, it 
is noteworthy that among the patients who died, almost 
all had experienced an acute myocardial infarction 
prior to the percutaneous treatment. The mortality of 
stable CAD in young individuals treated by percuta-
neous intervention does not suggest the presence of 
excessive malignancy. Compared with the expected 
mortality rate for the mean age of this cohort in the 
general population (subjects with a mean age of 43 
years at ten years follow-up), an overall mortality of 
5.49% is expected, according to data from the Bra-
zilian Institute of Geography and Statistics (Instituto 
Brasileiro de Geografia e Estatística – IBGE).7
Few studies have been conducted on stable CAD 
in a young population, and the results available in 
the literature are, in general, similar to those found 
in the present study. Another study conducted in a 
young population submitted to intervention found a 
mortality rate of 6.2% after a five-year follow-up, 
even though most patients in this study were admitted 
with unstable angina.6 In a recent study, the analysis 
of a population of young patients with premature 
coronary disease after percutaneous intervention 
showed a mortality between 6% and 7% at five-year 
follow-up; 63% of this sample of patients was treated 
after myocardial infarction and 66% were treated at 
urgent care or emergency departments.4
Although the mortality rate found in the study 
did not demonstrate an increased risk, the authors 
emphasise that this is not a study of the natural 
history of coronary heart disease. It is reasonable to 
hypothesise that, although aggressive, the appropriate 
treatment of coronary disease in this population could 
dramatically reduce the mortality rate compared with 
what is otherwise observed. Although the number of 
patients submitted to adequate initial pharmacological 
treatment when referred for invasive treatment was 
low (slightly over half of the patients were taking 
aspirin and one third were using statins, with no 
difference between patients with and without previ-
ous infarction), PCI may represent a milestone of 
treatment optimisation and encourage adherence to 
treatment. Even if such a claim cannot be formally 
demonstrated by the present findings, it is likely that 
the association of optimised clinical and percutaneous 
treatments is responsible for the benefit of reduced 
mortality in this young population.
To better assess the prognosis in relation to the 
general population, the investigation was expanded be-
yond the cardiovascular field and identified, in indexed 
journals in the Brazilian literature, comparative analysis 
cohorts of chronic diseases, all of a similar age range 
as the present sample, with mortality follow-up on an 
outpatient basis (Figure 3).
Diseased with aggressive behaviour, such as in 
patients with chronic kidney disease on early dialytic 
therapy with a mean age of 47.8 years, reached a 
mortality rate of 36.5% in three years. When associ-
ated with diabetes mellitus, the mortality was 74.5%.8 
Neoplasms are undoubtedly conditions of great malig-
nancy in young patients; patients with breast cancer9 
had a mortality of 25%, and patients with cervical 
cancer had a mortality of 20.4%, both after five years 
of follow-up.10 The analysis of stable outpatients with 
the human immunodeficiency virus (HIV) with a mean 
age of 36 years identified a mortality rate of 24.2% 
in eight years of follow-up.11 Even diseases sometimes 
regarded as lower risk compared with coronary disease 
were shown to be more aggressive, such as outpatients 
Figure 3 – Chart comparing the mortality in outpatient cohorts 
at similar age ranges. The delimited line refers to the mean 
morta lity in the age group of the general population, according 
to data from the Brazilian Institute of Geography and Statistics 
(Instituto Brasileiro de Geografia e Estatística – IBGE). The mor-
tality data were collected as available from SciELO/PubMed-
indexed literature. CAD + PCI = coronary artery disease treated 
by percutaneous coronary intervention; DM = diabetes mellitus; 
HIV = human immunodeficiency virus; CKD = chronic kidney disease 
(initial dialytic phase); Neo breast = unspecified breast cancer; 
Neo uterus = unspecified cervical neoplasia.
Mean mortality of the general
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aged between 40 and 49 years with tuberculosis, who 
exhibited a mortality rate of 17.4% in seven years.12
Study limitations
This study was a single-centre registry, and limita-
tions concerning this factor should be considered. This 
observational analysis after intervention did not attempt 
to compare therapeutics or even to predict the impact of 
specific treatment, whether percutaneous or drug therapy, 
but rather to describe the clinical evolution of this popu-
lation of 140 patients with an unusual presentation of 
CAD, considering that analyses related to this age group 
are not common in the literature, especially when the 
disease is not in its acute form. It is also noteworthy that 
the authors did not have access to the period prior to 
the CAD diagnosis for analysis in these patients, as they 
were included in the series when referred for interven-
tional treatment. Despite this limitation, the follow-up 
after percutaneous intervention therapy may represent a 
milestone of standardisation for the early follow-up of this 
population.
CONCLUSIONS
The primary finding of the present study was that 
young patients with chronic coronary artery disease 
treated by percutaneous coronary intervention in clini-
cal practice have a good prognosis.
In a context in which issues concerning the effec-
tiveness of the delayed treatment of coronary heart 
disease arise, these findings may ultimately contrib-
ute to the selection of a therapeutic strategy and an 
understanding of the prognosis in patients with early 
disease manifestation.
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